English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Arena Pharmaceuticals and Everest Medicines enter into a Partnership for Drug Development in China

Dec. 5, 2017

Arena Pharmaceuticals and Everest Medicines have entered into a development and commercialization partnership for ralinepag and etrasimod in mainland China, Taiwan, Hong Kong, Macau, and South Korea. In this context, C-Bridge Capital has invested $50 million to fund Everest and has assembled a veteran leadership team with an established track record in the development of innovative drugs and commercialization in China and globally. The companies aim to rapidly advance the product towards approval and launch.